Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
PLA2G2D (human)

Overview
PLA2G2D PA2 catalyzes the calcium-dependent hydrolysis of the 2- acyl groups in 3-sn-phosphoglycerides. L-alpha-1-palmitoyl-2- linoleoyl phosphatidylethanolamine is more efficiently hydrolyzed than the other phospholipids examined. Belongs to the phospholipase A2 family. Note: This description may include information from UniProtKB.
Protein type: Lipid Metabolism - linoleic acid; Lipid Metabolism - glycerophospholipid; EC 3.1.1.4; Secreted; Secreted, signal peptide; Lipid Metabolism - alpha-linolenic acid; Lipid Metabolism - ether lipid; Lipid Metabolism - arachidonic acid; Phospholipase
Cellular Component: extracellular region
Molecular Function: phospholipase A2 activity; calcium ion binding
Biological Process: phospholipid metabolic process; glycerophospholipid biosynthetic process; phosphatidic acid biosynthetic process; inflammatory response; lipid catabolic process
Reference #:  Q9UNK4 (UniProtKB)
Alt. Names/Synonyms: GIID sPLA2; Group IID secretory phospholipase A2; PA2GD; Phosphatidylcholine 2-acylhydrolase 2D; phospholipase A2, group IID; PLA2G2D; PLA2IID; secretory phospholipase A2s; Secretory-type PLA, stroma-associated homolog; sPLA2-IID; sPLA2S; SPLASH
Gene Symbols: PLA2G2D
Molecular weight: 16,546 Da
Basal Isoelectric point: 8.6  Predict pI for various phosphorylation states
Select Structure to View Below

PLA2G2D

Protein Structure Not Found.


STRING  |  Wikipedia  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  ENZYME  |  Phospho.ELM  |  Source  |  UCSD-Nature  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 Y82-p KTQGCSIyKDyyRYN
0 1 Y85-p GCSIyKDyyRYNFSQ
0 1 Y86-p CSIyKDyyRYNFSQG
0 1 Y126-p LKRNLDTyQKRLRFY
  mouse

 
L81 KIDGCKSLTDNYKYS
N84 GCKSLTDNYKYSISQ
Y85 CKSLTDNYKYSISQG
Y125 LKQNLDSYNKRLRYY
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.